Clinical Trials Logo

Brain Injuries, Traumatic clinical trials

View clinical trials related to Brain Injuries, Traumatic.

Filter by:

NCT ID: NCT02507271 Completed - Clinical trials for Traumatic Brain Injury

Speed of Processing Training in Traumatic Brain Injury

Start date: August 1, 2010
Phase: N/A
Study type: Interventional

The purpose of this project is to test the hypothesis that Speed of Information Processing (SIP) deficits in acquired brain injury (ABI) can be remediated. The majority of individuals with acquired brain injuries have speed of information processing deficits as part of the cognitive sequelae of the brain injury. Empirical research is expected to demonstrate the efficacy of computerized cognitive Speed of Information Processing (SIP) training in individuals with ABI. Study participants will be asked to attend two study visits over the course of approximately 13 weeks. Participants will be randomly assigned to either the experimental or control group.

NCT ID: NCT02504866 Terminated - Clinical trials for Traumatic Brain Injury (TBI)

Effect of Exercise Training on Physical, Cognitive, and Behavioral Function in People With TBI

Start date: December 15, 2016
Phase: N/A
Study type: Interventional

Background: - Traumatic brain injury (TBI) often causes problems with moving and balance, and thinking and emotions. Exercise can improve these things in people with other brain damage. Researchers want to look at the effect of exercise on these things in people with TBI. Objectives: - To study how head injuries affect the brain. To study if exercise can help some symptoms in people with TBI. These include problems thinking, balancing, and moving, and depression or anxiety. Eligibility: - People age between 18 and 79 - Had a non-penetrating TBI at least 12 months ago - Are physically inactive, but can stand and walk without help Design: - Participants will be screened with medical history, physical exam, and blood and urine tests. They may have a balance test. - Participants will be assigned to a high-intensity or a lower-intensity exercise program. - The study is 6 months long. There will be 3 months with exercise on an elliptical machine and 3 months without exercise. - Participants will exercise for 30 minutes on an elliptical machine, 3 days per week for 3 months. - Participants will also have 3 outpatient testing visits lasting approximately 8 hours, once every 3 months. This visit will include: - Blood tests - Tests for memory, attention, and thinking - Tests of walking and balance - Questionnaires - An MRI: they will lie in a machine that takes pictures of their brain, while breathing regular air and air with more carbon dioxide - Test of physical fitness

NCT ID: NCT02501941 Completed - Clinical trials for Traumatic Brain Injury

Spreading Depolarization and Ketamine Suppression

SAKS
Start date: July 2015
Phase: Phase 1
Study type: Interventional

Hypothesis: Cortical spreading depolarizations are inhibited by the NMDA receptor antagonist Ketamine Aim 1: To demonstrate, in a group of patients with acute severe brain injury requiring surgery including traumatic brain injury and aneurysmal subarachnoid hemorrhage, whether use of continuous infusion of ketamine decreases frequency of occurrence of cortical spreading depolarizations.

NCT ID: NCT02498262 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Using Virtual Reality and Robotics Technologies for Vocational Evaluation, Training and Placement

VR4VR
Start date: June 2015
Phase: N/A
Study type: Interventional

Using Virtual Reality and Robotics Technologies for Vocational Evaluation, Training and Placement (VR4VR) is a project that incorporates Virtual Reality into job training to increase job opportunities for people who have physical or mental disabilities. The investigators are using Virtual Reality and robotics for job evaluation, training and placement of people with disabilities. The investigators' goal is to assess and train people in a safe, adaptable, and fun virtual environment similar to a video game. This is an interventional study with three target populations: autism spectrum disorder, traumatic brain injury, and severe mobility and manipulation impairments. The prototype system allows for a wide range of environments with the vocational evaluator easily controlling the virtual experience, while the job seekers interact realistically.

NCT ID: NCT02496975 Withdrawn - Clinical trials for Traumatic Brain Injury

Traumatic Brain Injury and Effects of Acute Cyclosporine A

Start date: August 7, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This is a prospective, randomized, placebo-controlled study about Cyclosporine A (CSP) and traumatic brain injury (TBI). Cyclosporine A is a drug already marketed and available for other diseases, but is not approved by the Food and Drug Administration for treatment of traumatic brain injury. The effect of Cyclosporine A on chemicals produced following brain injury is being determined using doses no larger than those used for patients having organ transplant. It is also being given for a much shorter time period (3 days). It is not know if side effects seen in patients taking cyclosporine A will occur when it is given for only 3 days. It is not known if patients with brain injury that are treated with cyclosporine A will have side effects like those seen in organ transplant patients.

NCT ID: NCT02486003 Completed - Clinical trials for Mild Traumatic Brain Injury

Testing mTBI in Athletes

Start date: May 2015
Phase: N/A
Study type: Observational

This study will assess the effectiveness of a portable goggle system in the diagnosis of mild traumatic brain injury (mTBI) in athletes.

NCT ID: NCT02477943 Completed - Clinical trials for Brain Injuries, Traumatic

Objective Brain Function Assessment of mTBI/Concussion in College Athletes

AheadCAS
Start date: August 8, 2015
Phase:
Study type: Observational

This study (Part 1) is designed to build a database including EEG, neurocognitive performance, clinical symptoms, history and other relevant data, which will be used to derive a multimodal EEG based algorithm for the identification of concussion and tracking of recovery. In addition, neuroimaging will be conducted at time of injury and following Return to Play (RTP).

NCT ID: NCT02443142 Withdrawn - Brain Concussion Clinical Trials

Ibuprofen Versus Acetaminophen for Treatment of Mild Traumatic Brain Injury

IVAMTBI
Start date: May 1, 2015
Phase: Phase 2
Study type: Interventional

Traumatic brain injury (TBI) is an important public health problem with an estimated 1.7 million new cases in the United States each year. Although the vast majority of these victims sustain mild TBI, many still develop headache, difficulty concentrating, and decreased memory with potential for serious long-term consequences. In particular, mild TBI is an important consequence of combat-related injuries sustained by military personnel and sports-related injuries in young adults. Unfortunately, treatment of mild TBI is usually limited to oral analgesics for headache pain such as acetaminophen (Tylenol) or ibuprofen (Motrin or Advil). Since there are no previous randomized trials of these medications for mild TBI, their comparative effectiveness is not known. Increasing animal based evidence suggests that mild TBI is related to brain cell injury caused by overexpression of a cellular enzyme (COX-2) that causes neuroinflammation. Fortunately, inhibition of COX-2 is easily achieved using ibuprofen. We hypothesize that head injured patients treated with ibuprofen will have a lower incidence of mild TBI symptoms than patients treated with acetaminophen. We will conduct a randomized clinical trial to measure the comparative effects of ibuprofen versus acetaminophen on the incidence of specific symptoms of mild TBI in emergency department patients with head injury.

NCT ID: NCT02432300 Completed - Clinical trials for Traumatic Brain Injury

The Emotion Builder: An Intervention for Emotional Deficits After Brain Injury

Start date: May 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to examine a web-based training program for treating emotional problems in people who have suffered a traumatic brain injury (TBI).

NCT ID: NCT02429167 Completed - Clinical trials for Traumatic Brain Injury

Study of Safety and Effectiveness of PoNS Device to Treat Chronic Balance Deficit Due to Traumatic Brain Injury (TBI)

Start date: August 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if clinic and home training with a study device will improve a balance deficit. The study device is called Portable Neuromodulation Stimulator (PoNS). The study device will be placed on the tongue to deliver nerve stimulation. The study is testing if use of the study device in conjunction with physical therapy will improve balance and gait in patients suffering from a TBI. The effects of using the device and undergoing therapy will be measured using standardized tests of movement control, gait, headache and other TBI symptoms.